BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28043074)

  • 1. Comparative QSAR studies using HQSAR, CoMFA, and CoMSIA methods on cyclic sulfone hydroxyethylamines as BACE1 inhibitors.
    Zhang S; Lin Z; Pu Y; Zhang Y; Zhang L; Zuo Z
    Comput Biol Chem; 2017 Apr; 67():38-47. PubMed ID: 28043074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
    Zhang S; Hou B; Yang H; Zuo Z
    Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors.
    Jiang YR; Yang YY; Chen YL; Liang ZJ
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):385-95. PubMed ID: 24010934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2-propanols.
    Mondal C; Halder AK; Adhikari N; Jha T
    Comput Biol Med; 2013 Oct; 43(10):1545-55. PubMed ID: 24034746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
    Sainy J; Sharma R
    SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR.
    Sridhar J; Foroozesh M; Stevens CL
    SAR QSAR Environ Res; 2011 Oct; 22(7-8):681-97. PubMed ID: 22004550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
    Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
    Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined 2D and 3D-QSAR, molecular modelling and docking studies of pyrazolodiazepinones as novel phosphodiesterase 2 inhibitors.
    Bhansali SG; Kulkarni VM
    SAR QSAR Environ Res; 2014; 25(11):905-37. PubMed ID: 25401514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
    Gajjar KA; Gajjar AK
    Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An explorative study on potent Gram-negative specific LpxC inhibitors: CoMFA, CoMSIA, HQSAR and molecular docking.
    Shiri F; Salahinejad M; Dijoor R; Nejati-Yazdinejad M
    J Recept Signal Transduct Res; 2018 Apr; 38(2):151-165. PubMed ID: 29623756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative QSAR studies on peptide deformylase inhibitors.
    Lee JY; Doddareddy MR; Cho YS; Choo H; Koh HY; Kang JH; No KT; Pae AN
    J Mol Model; 2007 May; 13(5):543-58. PubMed ID: 17333308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.
    Zheng M; Yu K; Liu H; Luo X; Chen K; Zhu W; Jiang H
    J Comput Aided Mol Des; 2006 Sep; 20(9):549-66. PubMed ID: 17103017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
    Babu S; Sohn H; Madhavan T
    Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico screening for identification of pyrrolidine derivatives dipeptidyl peptidase-IV inhibitors using COMFA, CoMSIA, HQSAR and docking studies.
    Sharma MC; Jain S; Sharma R
    In Silico Pharmacol; 2017; 5():13. PubMed ID: 29098139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Analysis of Artimisinin Derivatives on the Antitumor Activities.
    Liu H; Liu X; Zhang L
    Nat Prod Bioprospect; 2017 Dec; 7(6):433-443. PubMed ID: 29094266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.
    da Cunha EF; Sippl W; de Castro Ramalho T; Ceva Antunes OA; de Alencastro RB; Albuquerque MG
    Eur J Med Chem; 2009 Nov; 44(11):4344-52. PubMed ID: 19616874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
    Lu P; Wei X; Zhang R
    Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors: Molecular insights into affinity and selectivity.
    Garcia ML; de Oliveira AA; Bueno RV; Nogueira VHR; de Souza GE; Guido RVC
    Drug Dev Res; 2022 Apr; 83(2):264-284. PubMed ID: 32045013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.